  See all
 |
Articles: Major Studies |
Abbott Initiates U.S. Study of Absolute Pro Peripheral Stent System for Iliac Artery Disease
Abbott, 04/02/09
Avigen Announces Positive Data for AV411 in Pain Relief and Drug Addiction
Avigen, 04/02/09
Free full text
Fluorescent Ligands of the Bradykinin B1 Receptors: Pharmacologic Characterization and Application to the Study of Agonist-Induced Receptor Translocation and Cell Surface Receptor Expression
Journal of Pharmacology and Experimental Therapeutics, 04/01/09 GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine
GlaxoSmithKline, 04/01/09
Free full text
Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
Amylin Pharmaceuticals, 04/01/09
Free full text
Plavix Plus Aspirin More Effective Than Aspirin Alone in Preventing Major Vascular Events in Patients with Atrial Fibrillation Who Cannot Take Oral Anticoagulants
Bristol Myers-Squibb Company, 04/01/09
Free full text
Patients receiving hemodialysis for treatment of end stage renal disease did not benefit from statin therapy in the AURORA study
AstraZeneca, 03/31/09
Free full text
Cytokinetics Announces Final Phase IIA Clinical Trial Data for CK-1827452 Presented at The 2009 Annual Scientific Sessions of The American College of Cardiology
Cytokinetics, 03/31/09
Free full text
New Data for Abbott's TRILIPIX (fenofibric acid) in Combination With CRESTOR (rosuvastatin calcium) Shows Improvement on Key Lipids for Cholesterol Management
Abbott, 03/30/09 CRESTOR reduced CV risk in patients achieving low LDL and hsCRP targets in new JUPITER analysis
AstraZeneca, 03/30/09
Free full text
Dapagliflozin Clinical Trial Results Indicate Improvement In Key Glycemic Measures In Treatment-Naive Type 2 Diabetes Patients
Bristol Myers-Squibb Company, 03/30/09
Free full text
Influence of Solid-State Acidity on the Decomposition of Sucrose in Amorphous Systems II (Effect of Buffer)
Drug Development and Industrial Pharmacy, 03/27/09 Application of Artificial Intelligent Tools to Modeling of Glucosamine Preparation from Exoskeleton of Shrimp
Drug Development and Industrial Pharmacy, 03/27/09 ImClone Systems and Bristol-Myers Squibb Provide Erbitux -Cetuximab- Non-Small Cell Lung Cancer Clinical Development Update
Bristol Myers-Squibb Company, 03/27/09
Free full text
Ustekinumab in the therapy of chronic plaque psoriasis
Biologics: targets & therapy, 03/26/09
Evidence Based Medicine
Investigational Hepatitis B Agent entecavir Demonstrated Statistically Significant Improvement Over lamivudine in Chronically Infected Hepatitis B Patients
Bristol Myers-Squibb Company, 03/26/09
Free full text
Gilead Initiates Phase II Clinical Trial of Cicletanine for the Treatment of Pulmonary Arterial Hypertension
Gilead, 03/25/09
Free full text
Concomitant Use of the 3-Dose Oral Pentavalent Rotavirus Vaccine With a 3-Dose Primary Vaccination Course of a Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio-Haemophilus influenzae Type b Vaccine: Immunogenicity and Reactogenicity
The Pediatric Infectious Disease Journal, 03/24/09 Array BioPharma Initiates Phase 1 Clinical Trial for MEK Inhibitor ARRY-300
Array BioPharma, 03/24/09
Free full text
Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kB inactivation
Journal of Pharmacy and Pharmacology, 03/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
171 Available Pages
|
|
